Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Jan 21, 2009; 15(3): 366-368
Published online Jan 21, 2009. doi: 10.3748/wjg.15.366
Published online Jan 21, 2009. doi: 10.3748/wjg.15.366
Table 1 Baseline characteristics of study and placebo groups
| Study group | Placebo group | P | |
| Demographic characteristics | |||
| Number | 38 | 36 | |
| Sex ratio (M/F) | 15/23 | 16/20 | 0.665 |
| Mean age (yr) | 64.29 ± 13.40 | 63.36 ± 15.13 | 0.781 |
| Etiology | 0.972 | ||
| Choledocholithiasis (cases) | 33 | 31 | |
| Others(cases) | 5 | 5 | |
| Cholangiectasis (cases) | 26 | 20 | 0.254 |
| Treatment | 0.841 | ||
| Choledochostomy | 26 | 26 | |
| Stent intervention | 6 | 6 | |
| Sphincterotomy and drainage | 6 | 4 | |
| ERCP operating time (min) | 36.89 ± 20.51 | 40.00 ± 24.73 | 0.558 |
Table 2 Complications occurred in study and placebo groups
| Group | PEP | Hyperamylasemia | Normal |
| Study | 3 | 8 | 27 |
| Placebo | 9 | 13 | 14 |
| P | 0.012 | 0.037 |
- Citation: Hao JY, Wu DF, Wang YZ, Gao YX, Lang HP, Zhou WZ. Prophylactic effect of glyceryl trinitrate on post-endoscopic retrograde cholangiopancreatography pancreatitis: A randomized placebo-controlled trial. World J Gastroenterol 2009; 15(3): 366-368
- URL: https://www.wjgnet.com/1007-9327/full/v15/i3/366.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.366
